totalmarketcap

Largest biotechnology: in vitro & in vivo diagnostic substances companies

Every US-listed biotechnology: in vitro & in vivo diagnostic substances company we cover — 19 of them — ranked by market capitalisation, with revenue and earnings taken from their SEC filings.

Combined market cap

$70.208 B

0.07% of all US-listed value

Companies

19

Ranked #97 of 152 industries

Largest

Idexx Laboratories

IDXX · market cap

Average

$3.695 B

Mean market cap per company

#NameMarket capCloseSessionCountry
1Idexx LaboratoriesIDXX$46.2B$586.67-0.56% United States
2LantheusLNTH$6.57B$100.95-0.12% United States
3Oruka TherapeuticsORKA$5.96B$98.82+0.41% United States
4Celldex TherapeuticsCLDX$3.27B$41.71+0.36% United States
5NeogenNEOG$2.50B$11.47+1.50% United States
6Intellia TherapeuticsNTLA$1.67B$11.94+6.23% United States
7Anbio BiotechnologyNNNN$1.53B$10.61+8.82% Germany
8QuidelOrthoQDEL$837.7M$12.29-24.72% United States
9Achieve Life SciencesACHV$682.7M$6.65+1.53% United States
10Alpha TeknovaTKNO$346.3M$6.46-1.07% United States
11Myriad GeneticsMYGN$311.8M$3.26+2.52% United States
12Insight Molecular DiagnosticsIMDX$156.0M$4.83+0.63% United States
13ImmucellICCC$99.5M$11.00-0.18% United States
14Q/C TechnologiesQCLS$22.9M$2.92+4.29% United States
15VolitionrxVNRX$9.34M$0.78+1.21% Singapore
16Trinity BiotechTRIB$8.39M$12.43+6.79% Ireland
17Cardio DiagnosticsCDIO$5.30M$1.79+7.83% United States
18BiomericaBMRA$4.98M$1.61+0.63% United States
19Virax Biolabs GroupVRAX$2.38M$2.98+7.58% United Kingdom

All 19 companies. One row per company — secondary share classes are folded into their primary listing. Updated 9 Aug 2026.

Sectors biotechnology: in vitro & in vivo diagnostic substances companies sit in

Other industries

Figures come from SEC filings and daily market prices. Companies listed only outside the US are not covered — see methodology.